Skip to main content

Table 1 Clinicopathological characteristics of patients and expression of SRPK1 in colon cancer samples

From: SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer

Clinicopathological No. (%)
Sex
 Male 83 (56.1)
 Female 65 (43.9)
Age (years)
  ≤ 60 47 (31.8)
  > 60 101 (68.2)
Stage (AJCC)
 I 40 (27.0)
 II 20 (13.5)
 III 54 (36.5)
 IV 34 (23.0)
T classification
 T1 25 (16.9)
 T2 22 (14.9)
 T3 24 (16.2)
 T4 77 (52.0)
N classification
 N0 72 (48.6)
 N1 53 (35.8)
 N2 18 (12.2)
 N3 5 (3.4)
M classification
 M0 114 (77.0)
 M1 34 (23.0)
Survival (n = 75)
 Alive 51 (68.0)
 Dead 24 (32.0)
Survival time of patients with low SRPK1 expression
 Mean 45.03
 Median 47.00
Survival time of patients with high SRPK1 expression
 Mean 38.82
 Median 46.00
Expression of SRPK1
 Low expression 51(34.5)
 High expression 97(65.5)